Creative Planning’s CASI Pharmaceuticals CASI Stock Holding History

Creative Planning’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,002	Closed	-$62K	–	2128
2021 Q2	$62K	Buy	4,002 +1	+0%	+$17	﹤0.01%	1920
2021 Q1	$96K	Buy	+4,001	New	+$112K	﹤0.01%	2255
2017 Q3	–	Sell	-149	Closed	-$2K	–	2155
2017 Q2	$2K	Buy	149 +148	+14,800%	+$1.57K	﹤0.01%	4285
2017 Q1	$0	Hold	1	–	–	﹤0.01%	4663
2016 Q4	$0	Hold	1	–	–	﹤0.01%	4629
2016 Q3	$0	Hold	1	–	–	﹤0.01%	4576
2016 Q2	$0	Hold	1	–	–	﹤0.01%	4361
2016 Q1	$0	Hold	1	–	–	﹤0.01%	4341
2015 Q4	$0	Hold	1	–	–	﹤0.01%	4417
2015 Q3	$0	Buy	+1	New	+$14	﹤0.01%	4295
2015 Q2	–	Sell	-7	Closed	–	–	1375
2015 Q1	$0	Hold	7	–	–	﹤0.01%	4222
2014 Q4	$0	Hold	7	–	–	﹤0.01%	4161
2014 Q3	$0	Buy	+7	New	+$124	﹤0.01%	4000
2014 Q2	–	Sell	-6	Closed	–	–	3784
2014 Q1	$0	Buy	+6	New	+$113	﹤0.01%	3636

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Creative Planning's CASI Position: Q3 2021 in Review

Creative Planning sold out of CASI Pharmaceuticals (CASI) in Q3 2021, closing a stake of 4,002 shares — an estimated $62K sold.

Creative Planning first reported a position in CASI in Q1 2014 and held it in 14 quarters. The position peaked at $96K in Q1 2021. 58 funds tracked by Wall St. Rank hold CASI as of Q3 2021.

Creative Planning reported no remaining CASI Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Creative Planning sold 4,002 CASI Pharmaceuticals shares in Q3 2021, an estimated $62K.
Creative Planning first reported a position in CASI Pharmaceuticals in Q1 2014 and held it in 14 quarters.
Creative Planning's CASI Pharmaceuticals position peaked at $96K in Q1 2021.
58 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2021.

Based on Creative Planning's 13F filing for Q3 2021, filed 10 Nov 2021.